LIF and breast cancer: To investigate whether the activation of mTOR pathway by LIF contributes to the role of LIF in breast cancer metastasis, rapamycin, a highly specific mTOR inhibitor, was employed to block the mTOR pathway, and the effect of LIF on invasion and migration was determined.